Enovis Corporation (0I1B.L)
- Previous Close
31.84 - Open
34.05 - Bid --
- Ask --
- Day's Range
34.05 - 34.10 - 52 Week Range
34.05 - 65.36 - Volume
427 - Avg. Volume
26 - Market Cap (intraday)
-- - Beta (5Y Monthly) 1.97
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
www.enovis.com7,367
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0I1B.L
View MorePerformance Overview: 0I1B.L
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0I1B.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0I1B.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-39.17%
Return on Assets (ttm)
0.73%
Return on Equity (ttm)
-27.65%
Revenue (ttm)
2.11B
Net Income Avi to Common (ttm)
-828.09M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
48.17M
Total Debt/Equity (mrq)
54.76%
Levered Free Cash Flow (ttm)
11.92M